Background: The relation and possible mechnism of vitamin D supplementation on
Background
Depression is an extremely frequent complication among survivors of colorectal cancer (CRC), with prevalence ranging from 24-57%. [1, 2] Depressive complication has been related to reduced quality of life [3] and increased mortality. [4] The profuseness of vitamin D receptors and vitamin D activating enzyme 1α-hydroxylase in the center nervous system suggests involvement of vitamin D in certain psychological processes. [5] Low concentrations of vitamin D have been associated with depression in both clinical and healthy populations. [6, 7] Moreover, recent prospective studies and clinical randomized controlled trials (RCT) have demonstrated positive effects of vitamin D supplementation on depression. [8, 9] Vitamin D deficiency is extremely frequent complication among CRC patients. [10 ] Low concentrations of vitamin D have been related to increased mortality among survivors of CRC. [11] Moreover, recent studies have demonstrated a positive effect of vitamin D supplementation on prognosis of CRC survivors. [12] . Base on both the involvement of vitamin D in depression in non-CRC individuals and high prevalence of vitamin D deficiency in CRC patients, whether vitamin D supplementation exerts positive effects on depression in CRC patients was examined.
Method

Study population and design
We prospectively recruited 168 outpatients with CRC in the clinics of two facilities in 
Outcome measure
The primary outcome evaluated absolute changes in HDRS-17 scores after 3 and 6 months of vitamin D treatment. For the HDRS-17, the widely-accepted definitions of response (at least a 50% reduction from baseline in the total score) were adopted in this study. [14] Statistical analysis OR, 6.358; 95% CI, 1.607-25.156, p = 0.008, respectively).
We excluded 38 patients for not meeting the predetermined supplementation criteria (n = 19) or because they declined our invitation (n = 19). Consequently, 130 (45 with and 85 without depression), began to take 2000 IU vitamin D3 per day for six months. Of these patients, the baseline characteristics were similar to those of the entire cohort. We observed reductions in HDRS-17 scores in depressed patients after 3 (9 vs.12, p < 0.001) and 6 months (8 vs. 12, p < 0.001). There was no change being observed in non-depressed patients (Fig. 1 ). The treatment response was consistent with the restoration of vitamin D concentrations, which increased to normal after 3 and 6 months in patients with (75.13
and 75.47 nmol/L, respectively) and without depression (76.71 and 77.07 nmol/L, respectively) (all p < 0.001). Specifically, we observed significant improvements (at least a 50% reduction from baseline in the total HDRS scores) in the majority of depressed patients after both 3 and 6 months.
Discussion
To our knowledge, this is the first report investigating the possible effects of vitamin D supplementation on depression in CRC patients. Our results suggest that serum concentrations of vitamin D were significantly associated with the presence of depression among CRC patients and vitamin D supplementation can improve depression in most CRC patients, which might have significant implications in providing novel proposal for the prevention and treatment of depressive complication in CRC patients.
We observed that serum concentrations of vitamin D were independently related to the presence of depression in CRC patients. Moreover, we found that the correction of vitamin D inadequacy exerts positive effects on depression in CRC patients. Caroline [9 ] found vitamin D supplementation significantly ameliorated depressive symptoms in women with chronic liver disease. Meanwhile, one randomized controlled trial showed vitamin D therapy was effective in decreasing perinatal depression concentrations. [8] The exact role of vitamin D in the pathophysiology of depression remains unknown. A possible explanation is the neuroprotective role for vitamin D via its effects on inflammatory response. A growing body of evidences has supported an important role of cytokines in the pathophysiology of depression. [15, 16] CRC patients have increased serum concentrations of the cytokines mentioned above. [17] Vitamin D plays a key role in modulating the secretion of cytokines. [18] Vitamin D may modulate the association of depression and inflammation via its role in the immune system. [19, 20] There are several limitations in this study. First, the effect of other potential factors on serum vitamin D concentrations, such as lifestyle changes, dietary intake, and seasonal variation, was not considered in this study. Second, the present study was not an RCT, a design we avoided owing to ethical concerns, as we were unwilling to withhold treatment for vitamin D inadequacy. Finally, the fluctuating characteristic of vitamin D makes it preferable to complete all measurements on the same day.
Conclusion
The results demonstrate depression was independently correlated with vitamin D concentrations in CRC patients. A therapeutic vitamin D supplementation may be recommended in CRC patients with low concentrations of vitamin D. Larger RCTs should be encouraged to confirm this study. Figure 1 Changes in depression during the study
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